Anterix (ATEX) EBITDA (2013 - 2026)

Anterix's EBITDA history runs 14 years deep, the most recent figure standing at $19.8 million for Q1 2026.

• Quarterly EBITDA rose 111.1% year-over-year to $19.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $93.9 million (up 901.86% YoY) and the FY2026 annual result came in at $93.9 million, up 901.86% from the prior year.
• EBITDA was $19.8 million for Q1 2026 at Anterix, up from -$9.1 million in the prior quarter.
• Across five years, EBITDA topped out at $60.7 million in Q3 2025 and bottomed at -$15.0 million in Q2 2024.
• A 5-year average of $2.6 million and a median of -$2.8 million in 2023 frame the typical range for EBITDA.
• Peak annual rise in EBITDA reached 625.7% in 2024, while the deepest fall reached 681.23% in 2024.
• Anterix's EBITDA stood at -$8.4 million in 2022, then soared by 111.53% to $969000.0 in 2023, then jumped by 625.7% to $7.0 million in 2024, then tumbled by 228.85% to -$9.1 million in 2025, then jumped by 318.91% to $19.8 million in 2026.
• Business Quant data shows ATEX's EBITDA at $19.8 million in Q1 2026, -$9.1 million in Q4 2025, and $60.7 million in Q3 2025.